Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
startups
achaogen
adams street partners
ajay royan
antibiotics
beta lactamase inhibitor
biology
biomedical advanced research and development authority (barda)
cancer
clinical trials
deals
drug resistance
drugs
events
fda
frederic moll
hatteras venture partners
health
investing
johnson & johnson
life sciences
lyzz capital
macrolide pharmaceuticals
melinta therapeutics
meropenem
michael dudley
moderna
mrna
national blog main
new enterprise associates
new york blog main
rempex pharmaceuticals
san diego
san diego blog main
san diego top stories
science
spero therapeutics
stanford university draper fund
tc
What
company
3
×
year
3
×
investor
medicines
addition
ajay
alltrna
announced
auris
bacteria
based
betting
billion
biopharma
business
called
ceo
come
companies
curious
developing
disease
diseases
disrupt
drug
entrepreneurs
exited
fighting
flagship
focus
following
frederic
hansen
household
hype
include
infections
infectious
intuitive
inventors
Language
unset
Current search:
company
×
year
×
biotech
×
@techcrunch.com
2 years ago
Flagship Pioneering’s new venture is betting on tRNA to treat “thousands of diseases”
@techcrunch.com
4 years ago
After selling Auris for $3.4 billion to J&J, CEO Frederic Moll and lead investor Ajay Royan come to Disrupt
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
